Propafenone
Back to searchMolecule Structure
Scientific Name
Propafenone
Description of the Drug
Propafenone is a Class 1C antiarrhythmic agent used in the management of paroxysmal atrial fibrillation/flutter and ventricular arrhythmias.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01182
http://www.drugbank.ca/drugs/DB01182
Brand Name(s)
Not Available
Company Owner(s)
Nesher Pharmaceuticals Usa Llc, Sun Pharmaceutical Industries Inc, Watson Laboratories, Watson Laboratories Inc, Sinotherapeutics Inc, Twi Pharmaceuticals Inc, Upsher Smith Laboratories Llc, Aurobindo Pharma Ltd, Ani Pharmaceuticals Inc, Glenmark Pharmaceuticals Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Beta-1 adrenergic receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL213 |
| Sodium channel alpha subunit | PROTEIN FAMILY | BLOCKER | CHEMBL2331043 |
| Beta-2 adrenergic receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL210 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL27865 | SCHEMBL16730120 | |
| PharmGKB | PA451131 | ||
| Human Metabolome Database | HMDB0015313 | ||
| DrugBank | DB01182 | ||
| PubChem: Thomson Pharma | 14900354 | ||
| PubChem | 4932 | ||
| Mcule | MCULE-8776872379 | ||
| LINCS | LSM-1416 | ||
| Nikkaji | J12.333A | ||
| BindingDB | 50067133 | ||
| EPA CompTox Dashboard | DTXSID9045184 | ||
| DrugCentral | 2291 | ||
| Brenda | 122954 | 229819 | 229818 |
| ChemicalBook | CB2854418 | CB2183169 | |
| Guide to Pharmacology | 2561 | ||
| rxnorm | PROPAFENONE | RYTHMOL | PROPAFENONE HYDROCHLORIDE |
| KEGG Ligand | C07381 | ||
| ChEBI | 63619 |
